Toxicity and efficacy of type I interferons on the ocular surface: in vitro, animal, and clinical studies
Authors:
- 11 July 2024
- journal article
- research article
- Published by Elsevier in The Ocular Surface
- Vol. 34, 96-107
Abstract
No abstract availableKeywords
Funding Information
- Doosan Yonkang Foundation (30-2023-0440)
This publication has 54 references indexed in Scilit:
- Mesenchymal Stem and Stromal Cells Harness Macrophage-Derived Amphiregulin to Maintain Tissue HomeostasisCell Reports, 2020
- Comparison of Topical 5-Fluorouracil and Interferon Alfa-2b as Primary Treatment Modalities for Ocular Surface Squamous NeoplasiaAmerican Journal of Ophthalmology, 2019
- Effects of TGFβ1, PDGF-BB, and bFGF, on human corneal fibroblasts proliferation and differentiation during stromal repairCytokine, 2017
- Long-term follow-up of conjunctival melanoma treated with topical interferon alpha-2b eye drops as adjunctive therapy following surgical resectionGraefe's Archive for Clinical and Experimental Ophthalmology, 2017
- Risk Factors for Ocular Surface Squamous Neoplasia Recurrence after Treatment With Topical Mitomycin C and Interferon Alpha-2bAmerican Journal of Ophthalmology, 2014
- Detection of Necrosis by Release of Lactate Dehydrogenase Activity2013
- Topical Interferon Alfa-2b for Management of Ocular Surface Squamous Neoplasia in 23 CasesArchives of Ophthalmology (1950), 2012
- Interferon α for the treatment of melanocytic conjunctival lesionsGraefe's Archive for Clinical and Experimental Ophthalmology, 2009
- Topical Interferon Alfa in the Treatment of Conjunctival Melanoma and Primary Acquired Melanosis ComplexAmerican Journal of Ophthalmology, 2008
- Topical Interferon Alfa-2b for the Treatment of Recalcitrant Ocular Surface Squamous NeoplasiaAmerican Journal of Ophthalmology, 2006